262 related articles for article (PubMed ID: 30614717)
1. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Robinson JD; Li L; Chen M; Lerman C; Tyndale RF; Schnoll RA; Hawk LW; George TP; Benowitz NL; Cinciripini PM
Psychol Addict Behav; 2019 Mar; 33(2):105-116. PubMed ID: 30614717
[TBL] [Abstract][Full Text] [Related]
2. Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
Cook JW; Lanza ST; Chu W; Baker TB; Piper ME
Nicotine Tob Res; 2017 Jun; 19(6):703-709. PubMed ID: 28486709
[TBL] [Abstract][Full Text] [Related]
3. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.
Piper ME; Vasilenko SA; Cook JW; Lanza ST
Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341
[TBL] [Abstract][Full Text] [Related]
4. Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
Gilbert DG; Rabinovich NE; Gilbert-Matuskowitz EA; Klein KP; Pergadia ML
Exp Clin Psychopharmacol; 2019 Dec; 27(6):536-551. PubMed ID: 30920255
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt.
Kim N; McCarthy DE; Piper ME; Baker TB
Addiction; 2021 Apr; 116(4):926-935. PubMed ID: 32888230
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
7. Transcranial Magnetic Stimulation Combined With Nicotine Replacement Therapy for Smoking Cessation: A Randomized Controlled Trial.
Trojak B; Meille V; Achab S; Lalanne L; Poquet H; Ponavoy E; Blaise E; Bonin B; Chauvet-Gelinier JC
Brain Stimul; 2015; 8(6):1168-74. PubMed ID: 26590478
[TBL] [Abstract][Full Text] [Related]
8. Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Zuo Y; Rabinovich NE; Gilbert DG
Psychopharmacology (Berl); 2017 Mar; 234(5):761-771. PubMed ID: 28028602
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
Schnoll RA; Hitsman B; Blazekovic S; Veluz-Wilkins A; Wileyto EP; Leone FT; Audrain-McGovern JE
Drug Alcohol Depend; 2016 Aug; 165():245-52. PubMed ID: 27372219
[TBL] [Abstract][Full Text] [Related]
10. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
11. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
12. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
[TBL] [Abstract][Full Text] [Related]
13. Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.
Kaye JT; Johnson AL; Baker TB; Piper ME; Cook JW
J Stud Alcohol Drugs; 2020 Jul; 81(4):426-435. PubMed ID: 32800078
[TBL] [Abstract][Full Text] [Related]
14. Why two smoking cessation agents work better than one: role of craving suppression.
Bolt DM; Piper ME; Theobald WE; Baker TB
J Consult Clin Psychol; 2012 Feb; 80(1):54-65. PubMed ID: 22103958
[TBL] [Abstract][Full Text] [Related]
15. Tobacco withdrawal components and their relations with cessation success.
Piper ME; Schlam TR; Cook JW; Sheffer MA; Smith SS; Loh WY; Bolt DM; Kim SY; Kaye JT; Hefner KR; Baker TB
Psychopharmacology (Berl); 2011 Aug; 216(4):569-78. PubMed ID: 21416234
[TBL] [Abstract][Full Text] [Related]
16. The effects of mindfulness-based yogic breathing on craving, affect, and smoking behavior.
Lotfalian S; Spears CA; Juliano LM
Psychol Addict Behav; 2020 Mar; 34(2):351-359. PubMed ID: 31750699
[TBL] [Abstract][Full Text] [Related]
17. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
[TBL] [Abstract][Full Text] [Related]
18. Mediators of the effect of nicotine pre-treatment on quitting smoking.
Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
[TBL] [Abstract][Full Text] [Related]
19. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
20. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
